ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · 2001
ClinicalTrials.gov · Datasets · License: Public Domain · 2001
Open Source ↗
alzheimer-diseasedementiamild-cognitive-impairment
dementia, alzheimer disease, mild cognitive impairment, galantamine hydrobromide, memory disorders, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 805969
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.